Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection
- PMID: 16406980
- DOI: 10.1016/S0022-5347(05)00162-X
Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection
Abstract
Purpose: Obesity has been associated with lower serum testosterone, theoretically resulting in decreased PSA production. Obesity has also been associated with prostatic enlargement, making the detection of existent cancer more difficult. Together these findings would result in an apparent protective effect of obesity on prostate cancer risk due to technical detection issues unrelated to cancer biology. We examined the association between BMI, and PSA and prostate weight in a cohort of men undergoing RP.
Materials and methods: We evaluated the association of BMI with prostate weight and PSA using linear regression, adjusting for patient age at RP, year of RP, race, and pathological stage and grade in 1,414 men treated with RP between 1988 and 2004 at the 5 equal access medical centers that comprise the Shared Equal Access Regional Cancer Hospital Database.
Results: On multivariate analysis increasing BMI was associated with increasing prostate weight but only in men younger than 63 years and not in men 63 years or older (p-trend <0.001 and 0.44, respectively). In men younger than 63 years mean multivariate adjusted prostate weight +/- SE in those with a BMI of less than 25 vs 30 to 34.9 kg/m was 33.8 +/- 1.4 vs 41.4 +/- 1.6 gm. There was no significant association between BMI and preoperative PSA (p-trend = 0.70).
Conclusions: In a cohort of men undergoing RP obesity was associated with larger prostate size but only in younger men. There was no association between BMI and PSA. Assuming equal PSA, the degree of prostatic enlargement observed in younger obese men in this study would be expected to result in a modest decrease in the odds of detecting prostate cancer in a contemporary series of PSA screened men due to the decreased sensitivity of cancer detection related to larger prostate size. Obesity may appear protective for prostate cancer in younger men due to technical issues unrelated to cancer biology.
Comment in
-
Re: Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. S. J. Freedland, E. A. Platz, J. C. Presti Jr., W. J. Aronson, C. L. Amling, C. J. Kane and M. K. Terris. J Urol, 175: 500-504, 2006.J Urol. 2006 Sep;176(3):1251-2; author reply 1252. doi: 10.1016/j.juro.2006.04.071. J Urol. 2006. PMID: 16890735 No abstract available.
Similar articles
-
Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.BJU Int. 2008 Sep;102(8):969-74. doi: 10.1111/j.1464-410X.2008.07934.x. Epub 2008 Aug 7. BJU Int. 2008. PMID: 18691175
-
The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.BJU Int. 2009 Nov;104(10):1457-61. doi: 10.1111/j.1464-410X.2009.08646.x. Epub 2009 Jun 12. BJU Int. 2009. PMID: 19522868
-
Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic.Urology. 2008 May;71(5):787-91. doi: 10.1016/j.urology.2007.11.036. Epub 2008 Feb 11. Urology. 2008. PMID: 18267334
-
Controversies in the early detection of prostate cancer.In Vivo. 1994 May-Jun;8(3):407-11. In Vivo. 1994. PMID: 7528555 Review.
-
Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen.Cancer Causes Control. 2020 May;31(5):431-449. doi: 10.1007/s10552-020-01291-3. Epub 2020 Mar 11. Cancer Causes Control. 2020. PMID: 32162172 Free PMC article.
Cited by
-
Obesity and future prostate cancer risk among men after an initial benign biopsy of the prostate.Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):898-904. doi: 10.1158/1055-9965.EPI-12-0965. Epub 2013 Apr 23. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23613026 Free PMC article.
-
Relationship between serum sex hormones levels and degree of benign prostate hyperplasia in Chinese aging men.Asian J Androl. 2012 Sep;14(5):773-7. doi: 10.1038/aja.2012.32. Epub 2012 Jul 2. Asian J Androl. 2012. PMID: 22751417 Free PMC article.
-
The Clinical Predictors of Malignancy in the Prostate Gland and Their Correlation With Prostate-Specific Antigen (PSA) Levels.Cureus. 2024 Jun 30;16(6):e63548. doi: 10.7759/cureus.63548. eCollection 2024 Jun. Cureus. 2024. PMID: 39086777 Free PMC article.
-
Association Between the Body Mass Index and Prostate Cancer at Biopsy is Modified by Genetic Risk: A Cross-Sectional Analysis in China.Medicine (Baltimore). 2015 Oct;94(42):e1603. doi: 10.1097/MD.0000000000001603. Medicine (Baltimore). 2015. PMID: 26496266 Free PMC article.
-
Body mass index and prostate cancer severity: do obese men harbor more aggressive disease on prostate biopsy?Urology. 2013 May;81(5):949-55. doi: 10.1016/j.urology.2013.01.021. Epub 2013 Mar 7. Urology. 2013. PMID: 23477756 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous